Caroline SPRINGER

City:

Sutton

Country:

United Kingdom

Published Applications:

Last publication date:

2022-11-24

Top Assignees for applications by Caroline SPRINGER

The entities that hold a legal rights for patent applications filed by inventor SPRINGER Caroline:

The Institute of Cancer Research: Royal Cancer Hospital 4 London, United Kingdom
Cancer Research Technology Limited 3 London, United Kingdom
Institute of Cancer Research: Royal Cancer Hospital (The) 3 London, United Kingdom

Recent patent applications by SPRINGER Caroline

Caroline SPRINGER from Sutton, GB has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2022-11-24

US20220372028A1

Chemistry; metallurgy

Methylamine derivatives as lysysl oxidase inhibitors for the treatment of cancer

#2 | 2021-02-11

US20210040078A1

Chemistry; metallurgy

Methylamine derivatives as lysysl oxidase inhibitors for the treatment of cancer

#3 | 2019-05-23

US20190152966A1

Chemistry; metallurgy

Methylamine derivatives as lysysl oxidase inhibitors for the treatment of cancer

#4 | 2016-02-04

US20160030405A1

Human necessities

1-(5-tert-butyl-2-phenyl-2H-pyrazol-3-yl)-3-[2-fluoro-4-(1-methyl-2-oxo-2,3-dihydro-1H-imidazo[4,5-B]pyridin-7-yloxy)-phenyl]-urea and related compounds and their use in therapy

#5 | 2014-12-04

US20140357663A1

Chemistry; metallurgy

1-(5-tert-butyl-2-phenyl-2H-pyrazol-3-yl)-3-[2-fluoro-4-(1-methyl-2-oxo-2,3-dihydro-1H-imidazo[4,5-b]pyridin-7-yloxy)-phenyl]-urea and related compounds and their use in therapy

#6 | 2012-11-08

US20120283288A1

Human necessities

1-(5-tert-butyl-2-phenyl-2H-pyrazol-3-yl)-3-[2-fluoro-4-(1-methyl-2-oxo-2,3-dihydro-1H-imidazo[4,5-B]pyridin-7-yloxy)-phenyl]-urea and related compounds and their use in therapy

InventorID:

992517 ⎘